in page functions

29 October 2010

AMC Baseline Study

The AMC Baseline Study presents an innovative new approach to public health funding as a way of stimulating and accelerating the development and manufacture of vaccines for developing countries.

01 September 2010

Serotype Replacement Note - Prepared by the IAC

The serotype replacement issue arises from extensive use of pneumococcal conjugate vaccine, which is expected to result in some increase of disease occurence due to serotypes not in the vaccine. This raises question whether the increases could reach a point where the benefit of the vaccine is lost, or the increases will be small relative to the decline in vaccine type disease.

23 August 2010

AMC IAC eligibility determination meeting: 23 August 2010

The purpose of the meeting was to review Pfizer’s application for AMC eligibility for Prevenar 13 and determine if the candidate vaccine met the TPP for the AMC.

16 June 2010

Remaining AMC offer amount 2010

The official formal notification of the remaining AMC Offer Amount.

16 April 2010

Minutes from AMC Eligibility Determination Meeting April 2010

Minutes from AMC Eligibility Determination Meeting held in London, UK on 16 April 2010.

16 April 2010


PneumoADIP is a small, dedicated team based at Johns Hopkins Bloomberg School of Public Health, supported by a $30 million grant from the GAVI Alliance.


close icon

modal window here